Background Vaccine-induced neutralising antibodies are a well-established correlate of protection against acquisition of COVID-19. Vaccine protection from severe COVID-19 remains high, although the role of neutralising antibodies and the contribution of other immune responses to protection from severe outcomes is less...
K. M. Elias, A. Mitchell, E. Stadler et al.· PLoS Medicine· 0 citations
BACKGROUND
People on immunosuppressive therapies are at increased risk of severe COVID-19, yet vaccine efficacy in these individuals has been inadequately assessed in randomised controlled trials. This systematic review and meta-analysis aims to examine vaccine effectiveness in people with medical conditions commonly t...
E. Stadler, Shanchita R. Khan, K. M. Elias et al.· The Lancet Microbe· 0 citations
Neutralizing antibodies are a correlate of protection (CoP) of SARS-CoV-2 vaccine efficacy. However, data informing CoPs often explicitly exclude people on immunosuppressive therapies who are at an increased risk of symptomatic and severe COVID-19, delayed viral clearance, and death. Investigating the relationship betw...
E. Stadler, S. R. Khan, K. M. Elias et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
